Indaptus Therapeutics is trading at $2.41, up 15.87% after announcing a $24 million private placement.

  • The financing includes 20,338,974 common shares and is intended for working capital, research and development, and general corporate purposes.
  • Shares gained 12.43% on September 9 and 51.64% on September 8, signaling unusually strong recent momentum.
  • The broader market is down, making the financing announcement the clearest catalyst.